Investor Presentaiton
Financial results
-
Investor Presentation
First nine months of 2018
Slide 16
First nine months of 2018
DKK million
Sales
Gross profit
9M 2018
9M 2017
Gross margin
Sales and distribution costs
Percentage of sales
Administration costs
Percentage of sales
Percentage of sales
Research and development costs
82,099
69,135
84.2%
20,669
10,261
12.5%
2,647
3.2%
83,704
70,772
20,045
10,031
2,666
Change
(reported)
(2%)
Change
(local currency)
4%
(2%)
84.6%
3%
9%
25.2%
23.9%
2%
5%
12.0%
(1%)
3%
3.2%
Other operating income, net
907
890
2%
Operating profit
36,465
38,920
(6%)
2%
Operating margin
44.4%
46.5%
Financial items (net)
780
(811)
Profit before income tax
37,245
38,109
Income taxes
7,114
8,232
(2%)
(14%)
Effective tax rate
19.1%
Net profit
30,131
Diluted earnings per share (DKK)
12.40
21.6%
29,877
1%
12.03
3%
9M: First nine months of 2018
changing
diabetes®View entire presentation